Endpoints News 生物医药· Reynald Castaneda·· 28 天前AI 评分20
ESMO26前瞻:Tango组合药物达Rasonque标准,Takeda押注Innovent获早期回报
Tango combo clears Rasonque bar, Takeda's Innovent bet gets early returns, plus more from #ESMO26
AI 导读
在今年的ESMO26大会上,Tango组合疗法达到了Rasonque设定的评估标准。此外,Takeda对Innovent的投资获得了早期的积极回报。由于文章正文被付费墙截断,未提供具体的试验数据、p值或生存率等关键指标。
正文
MADRID — While Friday is officially the first day of this year’s ESMO congress, some of the anticipation has deflated after keenly awaited data on Moderna …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news